Patent · US Active

Peptides for treatment of diabetes

US10815283B2 · kind B2 · utility

0Cited by

2References

24Claims

0Family size

Assignee

Follicum AB · SE

Inventors

Jan Alenfall · Lomma, SE
Pontus Dunér · Lund, SE
Anna NILSSON · Genarp, SE
Björn Walse · Lund, SE

Key dates

Filing date	Oct 29, 2019
Grant date	Oct 27, 2020
Priority date	—
Expiry date	Oct 29, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/40
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure concerns agents and their use in the treatment of endocrine, nutritional and/or metabolic diseases in a mammal. The disclosure furthermore concerns novel peptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.